Dr Lee Spindler Engel, MD | |
533 Bolivar St, Lsu-hsc, Csrb Room 307, New Orleans, LA 70112-1349 | |
(504) 599-1144 | |
(540) 568-7988 |
Full Name | Dr Lee Spindler Engel |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 23 Years |
Location | 533 Bolivar St, New Orleans, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245383660 | NPI | - | NPPES |
1043303 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 025616 (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Medical Center New Orleans | New orleans, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Louisiana State University School Of Medicine In New Orleans Faculty G | 0244136448 | 380 |
News Archive
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms.
New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
A single dose of buckwheat honey before bedtime provided the greatest relief from cough and sleep difficulty compared with no treatment and an over-the-counter cough medicine in children with upper respiratory tract infections, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
› Verified 4 days ago
Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms.
New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
A single dose of buckwheat honey before bedtime provided the greatest relief from cough and sleep difficulty compared with no treatment and an over-the-counter cough medicine in children with upper respiratory tract infections, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lee Spindler Engel, MD 322 Hay Pl, New Orleans, LA 70124-1512 Ph: (504) 909-9777 | Dr Lee Spindler Engel, MD 533 Bolivar St, Lsu-hsc, Csrb Room 307, New Orleans, LA 70112-1349 Ph: (504) 599-1144 |
News Archive
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms.
New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.
TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next generation product of its LipiFlow Thermal Pulsation System, a medical device that treats evaporative dry eye by liquefying and evacuating obstructions in meibomian glands located in the eyelids.
A single dose of buckwheat honey before bedtime provided the greatest relief from cough and sleep difficulty compared with no treatment and an over-the-counter cough medicine in children with upper respiratory tract infections, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
Novartis Pharmaceuticals Canada Inc. announced today that Lucentis (ranibizumab), the treatment for several major causes of vision loss, has been approved by Health Canada for the treatment of visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
› Verified 4 days ago
Leigh Victoria Deshotels, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # Sl50, New Orleans, LA 70112 Phone: -- | |
Dr. James Desporte Lilly, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2820 Napoleon Ave, Suite 720, New Orleans, LA 70115 Phone: 504-896-8670 Fax: 504-896-8699 | |
Carmen Gladys Espinoza, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1542 Tulane Ave, New Orleans, LA 70112 Phone: 504-903-1301 | |
Jose Rodrigo Restrepo, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: Department Of Radiology, 1542 Tulane Ave, Box T2-2, New Orleans, LA 70112 Phone: 504-568-4646 | |
Jorge Alan Martinez, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2021 Perdido St, New Orleans, LA 70112 Phone: 504-903-3000 | |
Dr. Princess Eronmwon Dennar, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave, Sl-16, New Orleans, LA 70112 Phone: 504-988-7518 Fax: 504-988-8252 | |
Eric Edward Holt I, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4747 Earhart Blvd Ste. J, New Orleans, LA 70125 Phone: 504-592-9818 Fax: 504-522-2248 |